These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 38240856)
1. Phellinus linteus activates Treg cells via FAK to promote M2 macrophage polarization in hepatocellular carcinoma. Chen F; Gong M; Weng D; Jin Z; Han G; Yang Z; Han J; Wang J Cancer Immunol Immunother; 2024 Jan; 73(1):18. PubMed ID: 38240856 [TBL] [Abstract][Full Text] [Related]
2. Ligustilide counteracts carcinogenesis and hepatocellular carcinoma cell-evoked macrophage M2 polarization by regulating yes-associated protein-mediated interleukin-6 secretion. Yang J; Xing Z Exp Biol Med (Maywood); 2021 Sep; 246(17):1928-1937. PubMed ID: 34053234 [TBL] [Abstract][Full Text] [Related]
3. Sargentodoxa cuneata and Patrinia villosa extract inhibits LPS-induced inflammation by shifting macrophages polarization through FAK/PI3K/Akt pathway regulation and glucose metabolism reprogramming. Liu X; Wang Y; Shao P; Chen Y; Yang C; Wang J; Cui S J Ethnopharmacol; 2024 Jan; 318(Pt A):116855. PubMed ID: 37390878 [TBL] [Abstract][Full Text] [Related]
4. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway. Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952 [TBL] [Abstract][Full Text] [Related]
5. IL-6/STAT3 pathway intermediates M1/M2 macrophage polarization during the development of hepatocellular carcinoma. Yin Z; Ma T; Lin Y; Lu X; Zhang C; Chen S; Jian Z J Cell Biochem; 2018 Nov; 119(11):9419-9432. PubMed ID: 30015355 [TBL] [Abstract][Full Text] [Related]
6. miR-210 promotes hepatocellular carcinoma progression by modulating macrophage autophagy through PI3K/AKT/mTOR signaling. Bi S; Zhang Y; Zhou J; Yao Y; Wang J; Fang M; Li B; Wu C; Ren C Biochem Biophys Res Commun; 2023 Jun; 662():47-57. PubMed ID: 37099810 [TBL] [Abstract][Full Text] [Related]
7. Cyclovirobuxine D Exerts Anticancer Effects by Suppressing the Zhang J; Chen Y; Lin J; Jia R; An T; Dong T; Zhang Y; Yang X DNA Cell Biol; 2020 Mar; 39(3):355-367. PubMed ID: 31913706 [TBL] [Abstract][Full Text] [Related]
8. Intestinal dysbacteriosis-induced IL-25 promotes development of HCC via alternative activation of macrophages in tumor microenvironment. Li Q; Ma L; Shen S; Guo Y; Cao Q; Cai X; Feng J; Yan Y; Hu T; Luo S; Zhou L; Peng B; Yang Z; Hua Y J Exp Clin Cancer Res; 2019 Jul; 38(1):303. PubMed ID: 31296243 [TBL] [Abstract][Full Text] [Related]
9. Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma. Niwa Y; Kanda H; Shikauchi Y; Saiura A; Matsubara K; Kitagawa T; Yamamoto J; Kubo T; Yoshikawa H Oncogene; 2005 Sep; 24(42):6406-17. PubMed ID: 16007195 [TBL] [Abstract][Full Text] [Related]
10. Crosstalk between hepatic tumor cells and macrophages via Wnt/β-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors. Yang Y; Ye YC; Chen Y; Zhao JL; Gao CC; Han H; Liu WC; Qin HY Cell Death Dis; 2018 Jul; 9(8):793. PubMed ID: 30022048 [TBL] [Abstract][Full Text] [Related]
11. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma. Liu L; Yang X; Li NF; Lin L; Luo H Cell Cycle; 2019 Nov; 18(21):2939-2953. PubMed ID: 31522588 [No Abstract] [Full Text] [Related]
12. Up-regulated cathepsin C induces macrophage M1 polarization through FAK-triggered p38 MAPK/NF-κB pathway. Alam S; Liu Q; Liu S; Liu Y; Zhang Y; Yang X; Liu G; Fan K; Ma J Exp Cell Res; 2019 Sep; 382(2):111472. PubMed ID: 31229505 [TBL] [Abstract][Full Text] [Related]
13. PRL-3 facilitates Hepatocellular Carcinoma progression by co-amplifying with and activating FAK. Zhou Q; Zhou Q; Liu Q; He Z; Yan Y; Lin J; Chen Z; He C; Mao K; Wang J; Zhou Z; Xiao Z; Zhang J Theranostics; 2020; 10(22):10345-10359. PubMed ID: 32929353 [No Abstract] [Full Text] [Related]
14. CD68(+)HLA-DR(+) M1-like macrophages promote motility of HCC cells via NF-κB/FAK pathway. Wang H; Wang X; Li X; Fan Y; Li G; Guo C; Zhu F; Zhang L; Shi Y Cancer Lett; 2014 Apr; 345(1):91-9. PubMed ID: 24333724 [TBL] [Abstract][Full Text] [Related]
15. Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib. Zhou SL; Zhou ZJ; Hu ZQ; Huang XW; Wang Z; Chen EB; Fan J; Cao Y; Dai Z; Zhou J Gastroenterology; 2016 Jun; 150(7):1646-1658.e17. PubMed ID: 26924089 [TBL] [Abstract][Full Text] [Related]
16. MiR-101 targets DUSP1 to regulate the TGF-β secretion in sorafenib inhibits macrophage-induced growth of hepatocarcinoma. Wei X; Tang C; Lu X; Liu R; Zhou M; He D; Zheng D; Sun C; Wu Z Oncotarget; 2015 Jul; 6(21):18389-405. PubMed ID: 26158762 [TBL] [Abstract][Full Text] [Related]
17. Astragaloside IV inhibits the progression of liver cancer by modulating macrophage polarization through the TLR4/NF-κB/STAT3 signaling pathway. Min L; Wang H; Qi H Am J Transl Res; 2022; 14(3):1551-1566. PubMed ID: 35422920 [TBL] [Abstract][Full Text] [Related]
18. Sunitinib suppresses M2 polarization of macrophages in tumor microenvironment to regulate hepatocellular carcinoma progression. Kong Y; Guo L J Biochem Mol Toxicol; 2023 Jun; 37(6):e23333. PubMed ID: 36797997 [TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA cox-2 prevents immune evasion and metastasis of hepatocellular carcinoma by altering M1/M2 macrophage polarization. Ye Y; Xu Y; Lai Y; He W; Li Y; Wang R; Luo X; Chen R; Chen T J Cell Biochem; 2018 Mar; 119(3):2951-2963. PubMed ID: 29131381 [TBL] [Abstract][Full Text] [Related]
20. Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis. Wang LP; Lin J; Ma XQ; Xu DY; Shi CF; Wang W; Jiang XJ J Exp Clin Cancer Res; 2021 May; 40(1):177. PubMed ID: 34039401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]